SCRCM

Society for Clinical Research Coordination and Management

Clinical Trials Scientific Review and Monitoring (CTSRMC)

The NCI mandates that cancer-related research studies involving human subjects be formally approved by the CTSRMC before it can be activated for accrual by the IRB. This means that even if the IRB has reviewed the study, an investigator may not start accruing subjects until the receipt of a written approval letter from the CTSRMC.

The Clinical Trials Scientific Review and Monitoring Committee (CTSRMC) and the Data and Safety Monitoring Committee (DSMC) are committees mandated by National Cancer Institute (NCI) for all Designated Comprehensive Cancer Centers.

For more details, visit the Abramson Cancer Center`s (ACC) website.